Skip to main content Accessibility help
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2012
  • Online publication date: August 2012

Chapter 20 - Dehydroepiandrosterone and androstenedione

20.11 References

AchermannJC, SilvermanBL (2001) Dehydroepiandrosterone replacement for patients with adrenal insufficiency. Lancet 357:1381–1382
AlkatibAA, CosmaM, ElaminMB, EricksonD, SwigloBA, ErwinPJ, MontoriVM (2009) A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency. J Clin Endocrinol Metab 94:3676–3681
AllolioB, ArltW (2002) DHEA treatment: myth or reality?Trends Endocrinol Metab 13:288–294
AllolioB, ArltW, HahnerS (2007) DHEA: why, when, and how much – DHEA replacement in adrenal insufficiency. Ann Endocrinol (Paris) 68:268–273
AndusT, KleblF, RoglerG, BregenzerN, ScholmerichJ, StraubRH (2003) Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study. Aliment Pharmacol Ther 17:409–414
ArltW (2003) Management of the androgen-deficient woman. Growth Horm IGF Res 13 (Suppl A): S85–S89
ArltW, JustlHG, CalliesF, ReinckeM, HublerD, OettelM, ErnstM, SchulteHM, AllolioB (1998) Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 83:1928–1934
ArltW, HaasJ, CalliesF, ReinckeM, HublerD, OettelM, ErnstM, SchulteHM, AllolioB (1999a) Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens. J Clin Endocrinol Metab 84:2170–2176
ArltW, CalliesF, van VlijmenJC, KoehlerI, ReinckeM, BidlingmaierM, HueblerD, OettelM, ErnstM, SchulteHM, AllolioB (1999b) Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341:1013–1020
ArltW, CalliesF, AllolioB (2000) DHEA replacement in women with adrenal insufficiency – pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition. Endocr Res 26:505–511
ArltW, CalliesF, KoehlerI, van VlijmenJC, FassnachtM, StrasburgerCJ, SeibelMJ, HueblerD, ErnstM, OettelM, ReinckeM, SchulteHM, AllolioB (2001) Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion. J Clin Endocrinol Metab 86:4686–4692
ArltW, HammerF, SanningP, ButcherSK, LordJM, AllolioB, AnnaneD, StewartPM (2006) Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock. J Clin Endocrinol Metab 91:2548–2554
AuchusRJ, RaineyWE (2004) Adrenarche – physiology, biochemistry and human disease. Clin Endocrinol (Oxf) 60:288–296
BaradD, BrillH, GleicherN (2007) Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet 24:629–634
BarnhartKT, FreemanE, GrissoJA, RaderDJ, SammelM, KapoorS, NestlerJE (1999) The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 84:3896–3902
Barrett-ConnorE, Goodman-GruenD (1995) Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study. Circulation 91:1757–1760
BassindaleT, CowanDA, DaleS, HuttAJ, LeedsAR, WheelerMJ, KicmanAT (2004) Effects of oral administration of androstenedione on plasma androgens in young women using hormonal contraception. J Clin Endocrinol Metab 89:6030–6038
BasuR, Dalla ManC, CampioniM, BasuA, NairKS, JensenMD, KhoslaS, KleeG, ToffoloG, CobelliC, RizzaRA (2007) Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women. Diabetes 56:753–766
BaulieuEE, ThomasG, LegrainS, LahlouN, RogerM, DebuireB, FaucounauV, GirardL, HervyMP, LatourF, LeaudMC, MokraneA, Pitti-FerrandiH, TrivalleC, de LacharriereO, NouveauS, Rakoto-ArisonB, SouberbielleJC, RaisonJ, Le BoucY, RaynaudA, GirerdX, ForetteF (2000) Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge study to a sociobiomedical issue. Proc Natl Acad Sci USA 97:4279–4284
BeckhamSG, EarnestCP (2003) Four weeks of androstenedione supplementation diminishes the treatment response in middle aged men. Br J Sports Med 37:212–218
BensingS, BrandtL, TabarojF, SjobergO, NilssonB, EkbomA, BlomqvistP, KampeO (2008) Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin Endocrinol (Oxf) 69:697–704
BergthorsdottirR, Leonsson-ZachrissonM, OdenA, JohannssonG (2006) Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 91:4849–4853
BerrC, LafontS, DebuireB, DartiguesJF, BaulieuEE (1996) Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci USA 93:13410–13415
BhuiyanMS, TagashiraH, FukunagaK (2011) Dehydroepiandrosterone-mediated stimulation of sigma-1 receptor activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding. Cardiovasc Ther 29:219–230
BhuiyanS, FukunagaK (2010) Stimulation of Sigma-1 receptor by dehydroepiandrosterone ameliorates hypertension-induced kidney hypertrophy in ovariectomized rats. Exp Biol Med (Maywood) 235:356–364
BilgerM, SperawS, LaFranchiSH, HannaCE (2005) Androgen replacement in adolescents and young women with hypopituitarism. J Pediatr Endocrinol Metab 18:355–362
BinderG, WeberS, EhrismannM, ZaiserN, MeisnerC, RankeMB, MaierL, WudySA, HartmannMF, HeinrichU, BettendorfM, DoerrHG, PfaeffleRW, KellerE (2009) Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial. J Clin Endocrinol Metab 94:1182–1190
BlochM, SchmidtPJ, DanaceauMA, AdamsLF, RubinowDR (1999) Dehydroepiandrosterone treatment of midlife dysthymia. Biol Psychiatry 45:1533–1541
BrookeAM, KalingagLA, Miraki-MoudF, Camacho-HubnerC, MaherKT, WalkerDM, HinsonJP, MonsonJP (2006) Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement. J Clin Endocrinol Metab 91:3773–3779
BrownGA, VukovichMD, MartiniER, KohutML, FrankeWD, JacksonDA, KingDS (2000) Endocrine responses to chronic androstenedione intake in 30- to 56-year-old men. J Clin Endocrinol Metab 85:4074–4080
BrownGA, MartiniER, RobertsBS, VukovichMD, KingDS (2002) Acute hormonal response to sublingual androstenediol intake in young men. J Appl Physiol 92:142–146
BrownGA, DeweyJC, BrunkhorstJA, VukovichMD, KingDS (2004) Changes in serum testosterone and estradiol concentrations following acute androstenedione ingestion in young women. Horm Metab Res 36:62–66
CalfeeR, FadaleP (2006) Popular ergogenic drugs and supplements in young athletes. Pediatrics 117:e577–e589
CalliesF, FassnachtM, van VlijmenJC, KoehlerI, HueblerD, SeibelMJ, ArltW, AllolioB (2001) Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity. J Clin Endocrinol Metab 86:1968–1972
CassonPR, FaquinLC, StentzFB, StraughnAB, AndersenRN, AbrahamGE, BusterJE (1995) Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. Fertil Steril 63:1027–1031
CassonPR, LindsayMS, PisarskaMD, CarsonSA, BusterJE (2000) Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum Reprod 15:2129–2132
ChangDM, LanJL, LinHY, LuoSF (2002) Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum 46:2924–2927
CompagnoneNA, MellonSH (1998) Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc Natl Acad Sci USA 95:4678–4683
CummingDC, RebarRW, HopperBR, YenSS (1982) Evidence for an influence of the ovary on circulating dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab 54:1069–1071
DanenbergHD, Ben-YehudaA, Zakay-RonesZ, GrossDJ, FriedmanG (1997) Dehydroepiandrosterone treatment is not beneficial to the immune response to influenza in elderly subjects. J Clin Endocrinol Metab 82:2911–2914
DavisSR, PanjariM, StanczykFZ (2011) Clinical review: DHEA replacement for postmenopausal women. J Clin Endocrinol Metab 96:1642–1653
DayalM, SammelMD, ZhaoJ, HummelAC, VandenbourneK, BarnhartKT (2005) Supplementation with DHEA: effect on muscle size, strength, quality of life, and lipids. J Womens Health (Larchmt) 14:391–400
DeightonCM, WatsonMJ, WalkerDJ (1992) Sex hormones in postmenopausal HLA-identical rheumatoid arthritis discordant sibling pairs. J Rheumatol 19:1663–1667
DhatariyaK, BigelowML, NairKS (2005) Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women. Diabetes 54:765–769
DhatariyaKK, GreenlundLJ, BigelowML, ThapaP, ObergAL, FordGC, SchimkeJM, NairKS (2008) Dehydroepiandrosterone replacement therapy in hypoadrenal women: protein anabolism and skeletal muscle function. Mayo Clin Proc 83:1218–1225
DiamondP, CusanL, GomezJL, BelangerA, LabrieF (1996) Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol 150 Suppl: S43–S50
ErichsenMM, LovasK, SkinningsrudB, WolffAB, UndlienDE, SvartbergJ, FougnerKJ, BergTJ, BollerslevJ, MellaB, CarlsonJA, ErlichH, HusebyeES (2009) Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 94:4882–4890
FlynnMA, Weaver-OsterholtzD, Sharpe-TimmsKL, AllenS, KrauseG (1999) Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab 84:1527–1533
GiagulliVA, VerdonckL, GiorginoR, VermeulenA (1989) Precursors of plasma androstanediol- and androgen-glucuronides in women. J Steroid Biochem 33:935–940
GleicherN, BaradDH (2011) Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod Biol Endocrinol 9: 67
GleicherN, WeghoferA, BaradDH (2010) Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod Biol Endocrinol 8:140
GordonCM, LeBoffMS, GlowackiJ (2001) Adrenal and gonadal steroids inhibit IL-6 secretion by human marrow cells. Cytokine 16:178–186
GurnellEM, HuntPJ, CurranSE, ConwayCL, PullenayegumEM, HuppertFA, CompstonJE, HerbertJ, ChatterjeeVK (2008) Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. J Clin Endocrinol Metab 93:400–409
HackbertL, HeimanJR (2002) Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women. J Womens Health Gend Based Med 11:155–162
HahnerS, LoefflerM, FassnachtM, WeismannD, KoschkerAC, QuinklerM, DeckerO, ArltW, AllolioB (2007) Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab 92:3912–3922
HammerF, SubtilS, LuxP, Maser-GluthC, StewartPM, AllolioB, ArltW (2005) No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies. J Clin Endocrinol Metab 90:3600–3605
HartkampA, GeenenR, GodaertGL, BijlM, BijlsmaJW, DerksenRH (2010) Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial. Ann Rheum Dis 69:1144–1147
HazeldineJ, ArltW, LordJM (2010) Dehydroepiandrosterone as a regulator of immune cell function. J Steroid Biochem Mol Biol 120:127–136
HuntPJ, GurnellEM, HuppertFA, RichardsC, PrevostAT, WassJA, HerbertJ, ChatterjeeVK (2000) Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 85:4650–4656
IgwebuikeA, IrvingBA, BigelowML, ShortKR, McConnellJP, NairKS (2008) Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women. J Clin Endocrinol Metab 93:534–538
IruthayanathanM, O'LearyB, PaulG, DillonJS (2011) Hydrogen peroxide signaling mediates DHEA-induced vascular endothelial cell proliferation. Steroids 76:1483–1490
JakobiJM, KillingerDW, WolfeBM, MahonJL, RiceCL (2001) Quadriceps muscle function and fatigue in women with Addison's disease. Muscle Nerve 24:1040–1049
JankowskiCM, GozanskyWS, SchwartzRS, DahlDJ, KittelsonJM, ScottSM, Van PeltRE, KohrtWM (2006) Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial. J Clin Endocrinol Metab 91:2986–2993
JankowskiCM, GozanskyWS, KittelsonJM, Van PeltRE, SchwartzRS, KohrtWM (2008) Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens. J Clin Endocrinol Metab 93:4767–4773
JohannssonG, BurmanP, WirenL, EngstromBE, NilssonAG, OttossonM, JonssonB, BengtssonBA, KarlssonFA (2002) Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. J Clin Endocrinol Metab 87:2046–2052
KahnAJ, HalloranB, WolkowitzO, BrizendineL (2002) Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men. J Clin Endocrinol Metab 87:1544–1549
KicmanAT, BassindaleT, CowanDA, DaleS, HuttAJ, LeedsAR (2003) Effect of androstenedione ingestion on plasma testosterone in young women; a dietary supplement with potential health risks. Clin Chem 49:167–169
KimSS, BrodyKH (2001) Dehydroepiandrosterone replacement in Addison's disease. Eur J Obstet Gynecol Reprod Biol 97:96–97
KingDS, SharpRL, VukovichMD, BrownGA, ReifenrathTA, UhlNL, ParsonsKA (1999) Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. JAMA 281:2020–2028
KlineMD, JaggersED (1999) Mania onset while using dehydroepiandrosterone. Am J Psychiatry 156: 971
KolibianakisEM, VenetisCA, TarlatzisBC (2011) DHEA administration in poor responders. Hum Reprod 26:730–731; author reply:731
Kritz-SilversteinD, von MuhlenD, LaughlinGA, BettencourtR (2008) Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well-Ness (DAWN) Trial. J Am Geriatr Soc 56:1292–1298
LabrieF (2010) DHEA, important source of sex steroids in men and even more in women. Prog Brain Res 182:97–148
LabrieF, DiamondP, CusanL, GomezJL, BelangerA, CandasB (1997) Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 82:3498–3505
LabrieF, Luu-TheV, LabrieC, BelangerA, SimardJ, LinSX, PelletierG (2003) Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 24:152–182
LabrieF, ArcherD, BouchardC, FortierM, CusanL, GomezJL, GirardG, BaronM, AyotteN, MoreauM, DubeR, CoteI, LabrieC, LavoieL, BergerL, GilbertL, MartelC, BalserJ (2009) Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause 16:923–931
LahitaRG, BradlowHL, GinzlerE, PangS, NewM (1987) Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 30:241–248
LaughlinGA, Barrett-ConnorE (2000) Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. J Clin Endocrinol Metab 85:3561–3568
LaurineE, LafitteD, GregoireC, SereeE, LoretE, DouillardS, MichelB, BriandC, VerdierJM (2003) Specific binding of dehydroepiandrosterone to the N terminus of the microtubule-associated protein MAP2. J Biol Chem 278:29979–29986
LazaridisI, CharalampopoulosI, AlexakiVI, AvlonitisN, PediaditakisI, EfstathopoulosP, CalogeropoulouT, CastanasE, GravanisA (2011) Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis. PLoS Biol 9: e1001051
LederBZ, LongcopeC, CatlinDH, AhrensB, SchoenfeldDA, FinkelsteinJS (2000) Oral androstenedione administration and serum testosterone concentrations in young men. JAMA 283:779–782
LederBZ, CatlinDH, LongcopeC, AhrensB, SchoenfeldDA, FinkelsteinJS (2001) Metabolism of orally administered androstenedione in young men. J Clin Endocrinol Metab 86:3654–3658
LederBZ, LeblancKM, LongcopeC, LeeH, CatlinDH, FinkelsteinJS (2002) Effects of oral androstenedione administration on serum testosterone and estradiol levels in postmenopausal women. J Clin Endocrinol Metab 87:5449–5454
LibeR, BarbettaL, Dall'AstaC, SalvaggioF, GalaC, Beck-PeccozP, AmbrosiB (2004) Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism. J Endocrinol Invest 27:736–741
LindschauC, KirschT, KlingeU, KolkhofP, PetersI, FiebelerA (2011) Dehydroepiandrosterone-induced phosphorylation and translocation of FoxO1 depend on the mineralocorticoid receptor. Hypertension 58:471–478
LiuD, DillonJS (2002) Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). J Biol Chem 277:21379–21388
LiuD, IruthayanathanM, HomanLL, WangY, YangL, DillonJS (2008) Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms. Endocrinology 149:889–898
LovasK, Gebre-MedhinG, TrovikTS, FougnerKJ, UhlvingS, NedreboBG, MykingOL, KampeO, HusebyeES (2003) Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 88:1112–1118
MarkowitzJS, CarsonWH, JacksonCW (1999) Possible dihydroepiandrosterone-induced mania. Biol Psychiatry 45:241–242
MazatL, LafontS, BerrC, DebuireB, TessierJF, DartiguesJF, BaulieuEE (2001) Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc Natl Acad Sci USA 98:8145–8150
MeikleAW, DorchuckRW, AraneoBA, StringhamJD, EvansTG, SpruanceSL, DaynesRA (1992) The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J Steroid Biochem Mol Biol 42:293–304
MelezKA, BoegelWA, SteinbergAD (1980) Therapeutic studies in New Zealand mice. VII. Successful androgen treatment of NZB/NZW F1 females of different ages. Arthritis Rheum 23:41–47
MoralesAJ, NolanJJ, NelsonJC, YenSS (1994) Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78:1360–1367
MoralesAJ, HaubrichRH, HwangJY, AsakuraH, YenSS (1998) The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (Oxf) 49:421–432
NairKS, RizzaRA, O'BrienP, DhatariyaK, ShortKR, NehraA, VittoneJL, KleeGG, BasuA, BasuR, CobelliC, ToffoloG, Dalla ManC, TindallDJ, MeltonLJ 3rd, SmithGE, KhoslaS, JensenMD (2006) DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 355:1647–1659
NieschlagE, LoriauxDL, RuderHJ, ZuckerIR, KirschnerMA, LipsettMB (1973) The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man. J Endocrinol 57:123–134
NoordamC, DhirV, McNelisJC, SchlerethF, HanleyNA, KroneN, SmeitinkJA, SmeetsR, SweepFC, Claahsen-van der GrintenHL, ArltW (2009) Inactivating PAPSS2 mutations in a patient with premature pubarche. N Engl J Med 360:2310–2318
OkabeT, HajiM, TakayanagiR, AdachiM, ImasakiK, KurimotoF, WatanabeT, NawataH (1995) Up-regulation of high-affinity dehydroepiandrosterone binding activity by dehydroepiandrosterone in activated human T lymphocytes. J Clin Endocrinol Metab 80:2993–2996
OrentreichN, BrindJL, RizerRL, VogelmanJH (1984) Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:551–555
OrentreichN, BrindJL, VogelmanJH, AndresR, BaldwinH (1992) Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab 75:1002–1004
PanjariM, BellRJ, JaneF, WolfeR, AdamsJ, MorrowC, DavisSR (2009) A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido. J Sex Med 6:2579–2590
ParkerCR Jr, MixonRL, BrissieRM, GrizzleWE (1997) Aging alters zonation in the adrenal cortex of men. J Clin Endocrinol Metab 82:3898–3901
PercheronG, HogrelJY, Denot-LedunoisS, FayetG, ForetteF, BaulieuEE, FardeauM, MariniJF (2003) Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial. Arch Intern Med 163:720–727
Perez-NeriI, MontesS, Ojeda-LopezC, Ramirez-BermudezJ, RiosC (2008) Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanism of action and relevance to psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 32:1118–1130
RadfordDJ, WangK, McNelisJC, TaylorAE, HechenbergerG, HofmannJ, ChahalH, ArltW, LordJM (2010) Dehdyroepiandrosterone sulfate directly activates protein kinase C-beta to increase human neutrophil superoxide generation. Mol Endocrinol 24:813–821
RasmussenBB, VolpiE, GoreDC, WolfeRR (2000) Androstenedione does not stimulate muscle protein anabolism in young healthy men. J Clin Endocrinol Metab 85:55–59
ReedMJ, PurohitA, WooLW, NewmanSP, PotterBV (2005) Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr Rev 26:171–202
ReiterWJ, PychaA, SchatzlG, PokornyA, GruberDM, HuberJC, MarbergerM (1999) Dehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled study. Urology 53:590–594; discussion:594–595
RothMY, PageST, LinK, AnawaltBD, MatsumotoAM, MarckB, BremnerWJ, AmoryJK (2011) The effect of gonadotropin withdrawal and stimulation with human chorionic gonadotropin on intratesticular androstenedione and DHEA in normal men. J Clin Endocrinol Metab 96:1175–1181
SchmidtPJ, DalyRC, BlochM, SmithMJ, DanaceauMA, St ClairLS, MurphyJH, HaqN, RubinowDR (2005) Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry 62:154–162
SenA, HammesSR (2010) Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol 24:1393–1403
ShifrenJL, BraunsteinGD, SimonJA, CassonPR, BusterJE, RedmondGP, BurkiRE, GinsburgES, RosenRC, LeiblumSR, CaramelliKE, MazerNA (2000) Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343:682–688
ShufeltC, BretskyP, AlmeidaCM, JohnsonBD, ShawLJ, AzzizR, BraunsteinGD, PepineCJ, BittnerV, VidoDA, StanczykFZ, Bairey MerzCN (2010) DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health – National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Clin Endocrinol Metab 95:4985–4992
SklarCA, KaplanSL, GrumbachMM (1980) Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. J Clin Endocrinol Metab 51:548–556
SolerteSB, FioravantiM, VignatiG, GiustinaA, CravelloL, FerrariE (1999) Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I. J Clin Endocrinol Metab 84:3260–3267
SpencerJB, KleinM, KumarA, AzzizR (2007) The age-associated decline of androgens in reproductive age and menopausal Black and White women. J Clin Endocrinol Metab 92:4730–4733
SrinivasanM, IrvingBA, FryeRL, O'BrienP, HartmanSJ, McConnellJP, NairKS (2010) Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men. J Clin Endocrinol Metab 95:1617–1625
StanwaySJ, DelavaultP, PurohitA, WooLW, ThurieauC, PotterBV, ReedMJ (2007) Steroid sulfatase: a new target for the endocrine therapy of breast cancer. Oncologist 12:370–374
StickneyDR, AhlemCN, MorganE, ReadingCL, OnizukaN, FrinckeJM (2011) Phase I and phase II clinical trials of androst-5-ene-3beta,7beta,17beta-triol. Am J Transl Res 3:275–283
StrousRD, MaayanR, LapidusR, StryjerR, LustigM, KotlerM, WeizmanA (2003) Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry 60:133–141
SuginoM, OhsawaN, ItoT, IshidaS, YamasakiH, KimuraF, ShinodaK (1998) A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy. Neurology 51:586–589
SunkaraSK, CoomarasamyA (2011) Androgen pretreatment in poor responders undergoing controlled ovarian stimulation and in vitro fertilization treatment. Fertil Steril 95:e73–e74; author reply:e75
SuzukiT, SuzukiN, DaynesRA, EnglemanEG (1991) Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol 61:202–211
SuzukiT, SuzukiN, EnglemanEG, MizushimaY, SakaneT (1995) Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 99:251–255
SvecF, PorterJR (1998) The actions of exogenous dehydroepiandrosterone in experimental animals and humans. Proc Soc Exp Biol Med 218:174–191
TomlinsonJW, HoldenN, HillsRK, WheatleyK, ClaytonRN, BatesAS, SheppardMC, StewartPM (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357:425–431
ToporLS, AsaiM, DunnJ, MajzoubJA (2011) Cortisol stimulates secretion of dehydroepiandrosterone in human adrenocortical cells through inhibition of 3betaHSD2. J Clin Endocrinol Metab 96:E31–E39
TrivediDP, KhawKT (2001) Dehydroepiandrosterone sulfate and mortality in elderly men and women. J Clin Endocrinol Metab 86:4171–4177
van NiekerkJK, HuppertFA, HerbertJ (2001) Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation. Psychoneuroendocrinology 26:591–612
van ThielSW, RomijnJA, PereiraAM, BiermaszNR, RoelfsemaF, van HemertA, BallieuxB, SmitJW (2005) Effects of dehydroepiandrostenedione, superimposed on GH substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial. J Clin Endocrinol Metab 90:3295–3303
van VollenhovenRF, EnglemanEG, McGuireJL (1994) An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum 37:1305–1310
van VollenhovenRF, ParkJL, GenoveseMC, WestJP, McGuireJL (1999) A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. Lupus 8:181–187
VillarealDT, HolloszyJO (2004) Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial. JAMA 292:2243–2248
VillarealDT, HolloszyJO (2006) DHEA enhances effects of weight training on muscle mass and strength in elderly women and men. Am J Physiol Endocrinol Metab 291:E1003–E1008
VillarealDT, HolloszyJO, KohrtWM (2000) Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clin Endocrinol (Oxf) 53:561–568
von MuhlenD, LaughlinGA, Kritz-SilversteinD, BergstromJ, BettencourtR (2008) Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial. Osteoporos Int 19:699–707
WaxenbergSE, DrellichMG, SutherlandAM (1959) The role of hormones in human behavior. I. Changes in female sexuality after adrenalectomy. J Clin Endocrinol Metab 19:193–202
WeissEP, ShahK, FontanaL, LambertCP, HolloszyJO, VillarealDT (2009) Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. Am J Clin Nutr 89:1459–1467
WilliamsMR, LingS, DawoodT, HashimuraK, DaiA, LiH, LiuJP, FunderJW, SudhirK, KomesaroffPA (2002) Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J Clin Endocrinol Metab 87:176–181
WiserA, GonenO, GhetlerY, ShavitT, BerkovitzA, ShulmanA (2010) Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod 25:2496–2500
WitJM, LangenhorstVJ, JansenM, OostdijkWA, van DoornJ (2001) Dehydroepiandrosterone sulfate treatment for atrichia pubis. Horm Res 56:134–139
WolfOT, NeumannO, HellhammerDH, GeibenAC, StrasburgerCJ, DressendorferRA, PirkeKM, KirschbaumC (1997) Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 82:2363–2367
WolfOT, NaumannE, HellhammerDH, KirschbaumC (1998) Effects of dehydroepiandrosterone replacement in elderly men on event-related potentials, memory, and well-being. J Gerontol A Biol Sci Med Sci 53:M385–390
WolkowitzOM, ReusVI, KeeblerA, NelsonN, FriedlandM, BrizendineL, RobertsE (1999) Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156:646–649
WolkowitzOM, KramerJH, ReusVI, CostaMM, YaffeK, WaltonP, RaskindM, PeskindE, NewhouseP, SackD, De SouzaE, SadowskyC, RobertsE (2003) DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study. Neurology 60:1071–1076
YakinK, UrmanB (2011) DHEA as a miracle drug in the treatment of poor responders; hype or hope?Hum Reprod 26:1941–1944
YenSS, MoralesAJ, KhorramO (1995) Replacement of DHEA in aging men and women. Potential remedial effects. Ann N Y Acad Sci 774:128–142
YoungJ, CouzinetB, NahoulK, BraillyS, ChansonP, BaulieuEE, SchaisonG (1997) Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. J Clin Endocrinol Metab 82:2578–2585
ZhaiG, TeumerA, StolkL, PerryJR, VandenputL, CovielloAD, KosterA, BellJT, BhasinS, ErikssonJ, ErikssonA, ErnstF, FerrucciL, FraylingTM, GlassD, GrundbergE, HaringR, HedmanAK, HofmanA, KielDP, KroemerHK, LiuY, LunettaKL, MaggioM, LorentzonM, ManginoM, MelzerD, MiljkovicI, NicaA, PenninxBW, VasanRS, RivadeneiraF, SmallKS, SoranzoN, UitterlindenAG, VolzkeH, WilsonSG, XiL, ZhuangWV, HarrisTB, MurabitoJM, OhlssonC, MurrayA, de JongFH, SpectorTD, WallaschofskiH (2011) Eight common genetic variants associated with serum DHEAS levels suggest a key role in ageing mechanisms. PLoS Genet 7: e1002025
ZwainIH, YenSS (1999) Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology 140:3843–3852